Accelerated Pharma is a clinical-stage pharmaceutical company whose drug development strategy is based on individualized targeting of patients using genomics.
Developing drugs that target RNA-modifying proteins for new cancer therapies.
Adlai Nortye is a biopharmaceutical company discovering, developing and commercializing new drugs for cancer and metabolic diseases.
Annias Immunotherapeutics, Inc., is a clinical stage company focused on the development of novel immunotherapeutic approaches to treat cancers that contain Cytomegalovirus (CMV).
Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Uses a variety of techniques that include multiplexed PCR and lab automation.
AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need.
Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response.
Healthcare data analytics via the Cota Nodal Address classification system, which creates patient cohorts by categorizing patient-specific medical histories, information on their diseases, and ...
Develops glutamine antagonists "immune-metabolism" to improve immune responses against cancer tumors.
A preclinical company investigating the hypothesis that cutting off the supply of certain nutrients could arrest cancer’s growth. Filtricine is starting out by developing meal kits with ...
Basic research, cancer research, immunotherapy. Fred Hutchinson Cancer Research Center is dedicated to the elimination of cancer and related diseases as causes of human suffering and death ...
GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable the development of precision cancer drugs while improving patient outcomes.
Genenta is developing a gene transfer strategy into hematopoietic cells to target a specific anti-tumor protein. A disabled virus vector delivers the gene into the cells. A combination of ...
GenomOncology enables real-time clinical decision-making at the point-of-care for Molecular Pathologists, Clinical Oncologists and Cancer Informaticists in their research of cancer treatments and ...
Hudson Biopharma is currently focused on the discovery of new anticancer drugs and medications.
Invectys focuses on the development of anti-cancer therapeutic approaches in immunotherapy.
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).
iTeos Therapeutics is targeting the tumor microenvironment to enhance the effectiveness of T-cells at eradicating cancer
Jungla's Molecular Evidence Platform (MEP) is an active learning engine that continuously integrates clinical knowledge to systematically generate, evaluate, audit, and distribute evidence models ...
Kiadis Pharma is developing potentially life‑saving therapies for patients with late-stage blood cancers, who are in need of a transplant, an area of significant unmet medical need.
Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on developing new targeted therapies to treat cancer and liver diseases
Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with clinical information incorporate all new discoveries in treatment plans.
Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates
Notable Labs is a drug testing service to help oncologists identify actionable treatment options for people with blood cancers.
Nucleix has developed a method to read DNA Methylation changes.
At Omicsoft, we focus on biomarker data management, visualization, and analysis. In order to achieve our goal of being the leader in next generation sequencing, bioinformatics, and cancer genomics ...
Oncologie is developing next-generation biologics and small molecules. Oncologie's portfolio covers the spectrum of the cancer immunology landscape.
Pediatric brain tumor treatments
OrigiMed is a medical science and technology company that is focused on identifing cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to ...